Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Ruxolitinib treatment may cause eyelash growth.

Minoxidil, when used with a diuretic and β-blocking agent, can safely lower blood pressure in most children with severe hypertension due to kidney disease, with minimal side effects.

Metformin protects hair cells in lab tests but not in live animals.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Miliacin may help prevent hair loss and improve hair growth in mice with a condition similar to human baldness.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Minoxidil helps prevent hair loss from chemotherapy in rats.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Glibenclamide slows breast cancer cell growth by stopping cell division.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Imuvert can prevent some chemotherapy-induced hair loss.

Minoxidil can cause a rare but serious condition that leads to fluid buildup around the heart and drug-induced lupus.

Minoxidil treats high blood pressure and side effects can be managed.

New inhibitors may reduce gut toxicity from cancer drugs.

Letrozole reduces seizures but not brain damage in mice.

New compounds were made that are promising for prostate cancer therapy.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

One minoxidil-sensitive potassium channel exists in human hair follicles.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.